Financials
Financial year 2025
SILVER-MED from Villers-le-Bouillet, company number BE0543417358, closed financial year 2025 with a result of € 196,637 after tax. For that financial year SILVER-MED recorded a gross margin of € 819,019 and equity of € 2.1 million. Compared with financial year 2024, the result moved from € 393,324 to € 196,637. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 2.1 million
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 196,637
▼ 50% vs 2024
Profit after tax over the fiscal year.
€ 44,216
▼ 67% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.6 million.
People and assets in 2025
7
▲ 2.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 444,768
▲ 22% vs 2024
€ 63,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 10,408
▼ 36% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 291,423
▼ 18% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 60,750
▲ 25% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 416,670 | € 694,822 | € 983,668 | € 819,019 | ▼ 17% |
| Profit after taxes | € 84,017 | € 198,515 | € 393,324 | € 196,637 | ▼ 50% |
| Equity | € 1,279,949 | € 1,475,955 | € 1,866,770 | € 2,061,031 | ▲ 10% |
| Total debts | € 891,014 | € 885,978 | € 833,325 | € 779,187 | ▼ 6% |
| Cash | € 105,361 | € 74,126 | € 133,392 | € 44,216 | ▼ 67% |
| Land & buildings | € 879,450 | € 838,097 | € 796,744 | € 755,391 | ▼ 5% |
| Retained profit | € 827,412 | € 1,025,927 | € 1,419,250 | € 1,615,887 | ▲ 14% |
| Balance sheet total | € 2,170,963 | € 2,361,933 | € 2,700,095 | € 2,840,219 | ▲ 5% |
| Employees (FTE) | 2.6 | 3.5 | 4.6 | 7 | ▲ 2.4 |
Key figures of SILVER-MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SILVER-MED?
What happened at SILVER-MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 196,637 (▼ 50% vs 2024). Source: NBB ↗
- New establishment in Villers-le-Bouillet. KBO
- Start of the company according to the CBE. KBO
In short
From € 84,017 profit in 2022 to € 196,637 profit in 2025.
Paid € 317,346 in corporate taxes since 2022.
Best year ever: 2024, with € 393,324 profit.
On average € 117,000 of value added per employee in 2025.
Management
Behind SILVER-MED is François-Xavier OLIVIER. François-Xavier OLIVIER is also behind PHARMACIE DES FORGES and CABIDEX.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Rue de l'Entreprise 12
4530 Villers-le-Bouillet
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0543.417.358
- VAT number
- BE 0543.417.358
- Registered office
- Rue de l'Entreprise 12, 4530 Villers-le-Bouillet
- Names & denominations
- SILVER-MED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 2013
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Logistieke diensten
Overige vervoerondersteunende activiteiten